Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Using EORTC Risk Tables

被引：20

作者：

Altieri, Vincenzo Maria ^{[1
,3
]}

Castellucci, Roberto ^{[1
,3
]}

Palumbo, Pietro ^{[1
,3
]}

Verratti, Vittore ^{[1
,3
]}

Sut, Michal ^{[2
]}

Olivieri, Raffaella ^{[1
,3
]}

Manco, Rossella ^{[1
,3
]}

Ricciardulli, Stefano ^{[1
,3
]}

Nicolai, Michele ^{[1
,3
]}

Criniti, Pasquale ^{[1
,3
]}

Tenaglia, Raffaele Lanfranco ^{[1
,3
]}

机构：

[1] Univ G dAnnunzio, Sch Urol, Chieti, Italy

[2] Bedford Hosp NHS Trust, Bedford, England

[3] Univ G dAnnunzio, Dept Urol, Chair Urol, Chieti, Italy

来源：

UROLOGIA INTERNATIONALIS | 2012年 / 89卷 / 01期

关键词：

Non-muscle-invasive bladder cancer; Transurethral resection of the bladder; Second transurethral resection; Chemotherapy; lmmunotherapy; BACILLUS-CALMETTE-GUERIN; UROTHELIAL CARCINOMA; STAGE; EPIDEMIOLOGY; METAANALYSIS; GUIDELINES; DIAGNOSIS; TRIALS; DEATH; GRADE;

D O I：

10.1159/000336516

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives: It was the aim of this study to evaluate the recurrence and progression at 1, 3 and 5 years in patients with non-muscle-invasive bladder cancer (NMIBC) who underwent a transurethral resection of bladder cancer following intravesical adjuvant chemotherapy or immunotherapy if indicated and to compare them with the European Organization for Research and Treatment of Cancer (EORTC) risk tables. Patients and Methods: Between 2002 and 2011, a total of 259 patients with NMIBC were treated with transurethral resection of bladder cancer. According to the clinical and pathological factors used by the EORTC scoring system, the patients were divided into four groups, and for each group, the probabilities of recurrence and progression were calculated. Results: The recurrence and progression rates of NMIBC of our patients were similar to those in the EORTC risk score system. Moreover, in our sample group, we found a minimally significant reduction in the recurrence rate in the intermediate- and high-risk groups. Conclusion: From the results obtained, we considered it essential to introduce the use of EORTC risk tables into our clinical practice to determine the recurrence and progression of NMIBC. Copyright (C) 2012 S. Karger AG, Basel

引用

页码：61 / 66

页数：6

共 18 条

[1]

[Anonymous], 2002, TNM CLASSIFICATION M, DOI DOI 10.1002/0471463752

[2] DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality [J].

Baak, JPA ;

Bol, MGW ;

van Diermen, B ;

Janssen, EAM ;

Buhr-Wildhagen, SBK ;

Mestad, O ;

Ogreid, P ;

Kjellevold, KH .

UROLOGY, 2003, 61 (06) :1266-1272

[3]

Babjuk M, 2011, GUIDELINES NONMUSCLE, P4

[4] EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder [J].

Babjuk, Marko ;

Oosterlinck, Willem ;

Sylvester, Richard ;

Kaasinen, Eero ;

Boehle, Andreas ;

Palou-Redorta, Juan .

EUROPEAN UROLOGY, 2008, 54 (02) :303-314

[5] Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer:: A formal meta-analysis of comparative studies on recurrence and toxicity [J].

Böhle, A ;

Jocham, D ;

Bock, PR .

JOURNAL OF UROLOGY, 2003, 169 (01) :90-95

[6] The health economics of bladder cancer - A comprehensive review of the published literature [J].

Botteman, MF ;

Pashos, CL ;

Redaelli, A ;

Laskin, B ;

Hauser, R .

PHARMACOECONOMICS, 2003, 21 (18) :1315-1330

[7] Impact of Routine Second Transurethral Resection on the Long-Term Outcome of Patients with Newly Diagnosed pT1 Urothelial Carcinoma with Respect to Recurrence, Progression Rate, and Disease-Specific Survival: A Prospective Randomised Clinical Trial [J].

Divrik, Rauf Taner ;

Sahin, Ali F. ;

Yildirim, Uemit ;

Altok, Muammer ;

Zorlu, Ferruh .

EUROPEAN UROLOGY, 2010, 58 (02) :185-190

[8] Nuclear Matrix Protein 22 as Adjunct to Urine Cytology and Cystoscopy in Follow-up of Superficial TCC of Urinary Bladder [J].

Gupta, Narmada P. ;

Sharma, Nitin ;

Kumar, Rajeev .

UROLOGY, 2009, 73 (03) :592-596

[9] Cancer statistics, 2008 [J].

Jemal, Ahmedin ;

Siegel, Rebecca ;

Ward, Elizabeth ;

Hao, Yongping ;

Xu, Jiaquan ;

Murray, Taylor ;

Thun, Michael J. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2008, 58 (02) :71-96

[10] Bladder cancer: Epidemiology, staging and grading, and diagnosis [J].

Kirkali, Z ;

Chan, T ;

Manoharan, M ;

Algaba, F ;

Busch, C ;

Cheng, L ;

Kiemeney, L ;

Kriegmair, M ;

Montironi, R ;

Murphy, WM ;

Sesterhenn, IA ;

Tachibana, M ;

Weider, J .

UROLOGY, 2005, 66 (6A) :4-34

← 1 2 →